Literature DB >> 17487414

Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis.

Susan Cheung1, Joseph Tai.   

Abstract

Constituents in rosemary have shown a variety of pharmacological activities for cancer chemoprevention and therapy in in vitro and in vivo models. In order to further explore the chemopreventive properties of crude extracts of rosemary (Rosmarinus officinalis L), we studied its anti-proliferative property on several human cancer cell lines and its antioxidant and anti-inflammatory properties in vitro in a mouse RAW 264.7 macrophage/monocyte cell line. Our study shows that crude ethanolic rosemary extract (RO) has differential anti-proliferative effects on human leukemia and breast carcinoma cells. The 50% inhibitory concentration (IC50) was estimated at 1/700, 1/400, 1/150 and 1/500 dilutions, for the HL60, K562, MCF7 and MDA-MB-468 cells, respectively. Non-cytotoxic concentrations of RO at 1/1000 dilution minimally induced HL60 cell differentiation into granulocyte lineage at 9.5+/-2.2% compared to 2.8+/-0.8% in the untreated control (p<0.001), and did not induce HL60 cell differentiation into monocyte/macrophage lineage. The 6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox) equivalent antioxidant capacity assay showed that RO has substantial antioxidant activity with RO at 1/10 and 1/5 dilutions having 8.1 and 12.6 microM Trolox equivalents, respectively. RO at non-cytotoxic 1/2000 and 1/1000 dilutions did not affect nitric oxide (NO) production by non-stimulated RAW 264.7 cells. However, at the same dilutions RO significantly reduced NO production by lipopolysaccharide (LPS)-activated cells in a dose-dependent manner from 32.6+/-2.3 microM in the LPS-activated cells to 19.2+/-2.2 microM (p<0.01), and 7.7+/-1.2 microM (p<0.001), respectively. RT-PCR analyses showed that RAW 264.7 cells treated with 1/1000 and 1/500 dilutions for 5 h did not affect TNFalpha, IL-1beta, iNOS and COX-2 mRNA expression in these cells when compared to the untreated controls, nor did the 1/1000 dilution of RO affect TNFalpha, IL-1beta, iNOS and COX-2 mRNA expression in the LPS-activated cells. At 1/500 dilution, RO significantly reduced IL-1beta (p<0.01) and COX-2 (p<0.05) mRNA expression and non-significantly reduced TNFalpha and iNOS mRNA expression in the LPS-activated cells. In view of the chemopreventive potentials, further studies are needed to explore other biological properties of this popular spice used by many cultures in the world.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487414

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  38 in total

1.  Carnosic acid, a rosemary phenolic compound, induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells.

Authors:  Chia-Wen Tsai; Chia-Yuan Lin; Hui-Hsuan Lin; Jing-Hsien Chen
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

2.  Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines.

Authors:  Ozlem Yesil-Celiktas; Canan Sevimli; Erdal Bedir; Fazilet Vardar-Sukan
Journal:  Plant Foods Hum Nutr       Date:  2010-06       Impact factor: 3.921

3.  Neuroprotective effect of Rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y.

Authors:  Se-Eun Park; Seung Kim; Kumar Sapkota; Sung-Jun Kim
Journal:  Cell Mol Neurobiol       Date:  2010-02-21       Impact factor: 5.046

4.  Use of Systemic Rosmarinus Officinalis to Enhance the Survival of Random-Pattern Skin Flaps.

Authors:  Bilsev İnce; Fatma Bilgen; Ayşe Özlem Gündeşlioğlu; Mehmet Dadacı; Sümeyye Kozacıoğlu
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

5.  Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary.

Authors:  Auxiliadora López-Jiménez; Melissa García-Caballero; Miguel Ángel Medina; Ana R Quesada
Journal:  Eur J Nutr       Date:  2011-12-16       Impact factor: 5.614

6.  The anti-leukemic effect of carnosic acid combined with adriamycin in a K562/A02/SCID leukemia mouse model.

Authors:  Lu-Qun Wang; Ran Wang; Xiang-Xin Li; Xiao-Ning Yu; Xue-Liang Chen; Hao Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 7.  Natural products against cancer angiogenesis.

Authors:  El Bairi Khalid; El-Meghawry El-Kenawy Ayman; Heshu Rahman; Guaadaoui Abdelkarim; Agnieszka Najda
Journal:  Tumour Biol       Date:  2016-09-20

8.  Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines.

Authors:  Kristen A Scheckel; Stephanie C Degner; Donato F Romagnolo
Journal:  J Nutr       Date:  2008-11       Impact factor: 4.798

9.  Rosmarinus officinalis extract suppresses Propionibacterium acnes-induced inflammatory responses.

Authors:  Tsung-Hsien Tsai; Lu-Te Chuang; Tsung-Jung Lien; Yau-Rong Liing; Wei-Yu Chen; Po-Jung Tsai
Journal:  J Med Food       Date:  2013-03-20       Impact factor: 2.786

10.  Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells.

Authors:  M V Barni; M J Carlini; E G Cafferata; L Puricelli; S Moreno
Journal:  Oncol Rep       Date:  2012-01-11       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.